Back to search

United States· US:0113-2007_625c73b9-b448-4e9b-a1e6-359d5cb33eb0

Allergy and Congestion Relief

A medicinal product containing loratadine; pseudoephedrine sulfate, registered in United States by L. Perrigo Company.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAllergy and Congestion ReliefATC—REGISTER NO.US:0113-2007_625c73b9…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LORATADINE; PSEUDOEPHEDRINE SULFATE
Manufacturer
L. Perrigo Company
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0113-2007-60
  • ndc11
    0113200760
    20 BLISTER PACK in 1 CARTON (0113-2007-60) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Loratadine; pseudoephedrine sulfate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All loratadine; pseudoephedrine sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Clarinase
  • Belgium · Clarinase Once Daily, Clarinase Repetabs
  • Bulgaria · Клариназе
  • Cyprus · Clarityne-D
  • Czechia · Clarinase Repetabs
  • Denmark · Clarinase
  • Spain · Clarityne Plus, Narine Repetabs
  • Greece · Clarityne-D
  • Croatia · Clarinase
  • Iceland · Clarinase
  • Malta · Clarinase Repetabs
  • Poland · Claritine Active, Claritine Duo
  • Portugal · Claridon
  • Romania · Clarinase
  • Slovenia · Claritine Kombo
  • Slovakia · Clarinase Repetabs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee8c4a4a-7622-4da5-befc-b5130c30c9d1
GET /v1/drugs/ee8c4a4a-7622-4da5-befc-b5130c30c9d1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5; 120",
  "substance": "LORATADINE; PSEUDOEPHEDRINE SULFATE",
  "productndc": "0113-2007",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA076050",
  "marketing_category": "ANDA"
}

See everything about loratadine; pseudoephedrine sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.